Scan to Download
Subscription Pattern
Shares of the state-owned lender gained as much as 6.4 percent to Rs 169.90, highest since December 2015.
Union Bank gets board approval to raise Rs 6,350 crore in 2017-2018 through public issue, it said in a regulatory filing.
Volume 3.2 times its 30-day average.
#BQSpotted | Dhunseri Investment locked in 20% upper circuit.https://t.co/y7fa9nZSFc pic.twitter.com/Sf28qbN51e
— BloombergQuint (@BloombergQuint) April 28, 2017
A gauge of the country’s top 10 drug makers swung between gains and losses, after declining in the previous two sessions.
The Nifty Pharma index is one of the worst performers so far this year, bogged down by regulatory and pricing concerns. Also, adding to the list of concerns for the export-oriented firms was the rupee’s rally to near 21-month high.
Nifty Pharma index was unchanged after losing little over 4 percent in two weeks.
Meanwhile, India’s drug pricing authority, the NPPA has notified ceiling prices of eight scheduled formulations under the DPCO 2016 [Drugs (Prices Control) Amendment Order, 2016] and revised prices of another five formulations.
Drugs whose ceiling prices were fixed included vancomycin (antibiotic) and Etoposide (anti cancer drug).
.@KotakBankLtd buys out its life insurance joint venture partner's stake for Rs 1,293 crore.https://t.co/vQjeQIa8Nj pic.twitter.com/pOAgaxwpLs
— BloombergQuint (@BloombergQuint) April 28, 2017
Shares of the state-owned firm jumped as much as 10.1 percent to their highest level since August 2013.
ITDC signed an agreement for the transfer of equity stake in its joint venture subsidiaries.
For a list of stocks that are moving the market, clik here
(With inputs from PTI)
For India's millenials, gold isn't the preferred choice.https://t.co/GUG0P4VsKN pic.twitter.com/xmdsWsvoDT
— BloombergQuint (@BloombergQuint) April 27, 2017
*Buyers and sellers were not immediatley known
Shares of the cement maker gained as much as 9.2 percent to Rs 129.20, highest since March 2016.
Madhya Pradesh government allotted cement grade limestone mining lease to Prism Cement for 50 years, the company said in a regulatory filing.
Volume at 26.5 times its 30-day average volume.
Also Read: Biocon Misses Estimates As Profit Falls Due To High Base Effect
Indian shares declined for a second straight session, dragged down by pharmaceutical firm Biocon on lower-than-expected earnings while weak Asian cues also weighed on sentiment.
The S&P BSE Sensex fell 0.29 percent to 29,946, while the NSE Nifty shed 0.34 percent at 9,310.
Among the sectoral indices, S&P BSE Technology index fell 0.39 percent while S&P BSE Realty index declined 0.70 percent.
The market breadth was, however, skewed in the favour of gainers, with about 6 stocks advancing to every 4 stocks that declined.
For a complete list of stocks, click HERE
India will overtake Germany in 2022 as the world's 4th-largest economy, push Britain out of top 5. @anir_nag reportshttps://t.co/ETqhtwuq9p pic.twitter.com/DZOPsgFuQF
— BloombergQuint (@BloombergQuint) April 28, 2017
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
